monoclonal antibodies

bird birds flying humingbirds
Biotech

Hummingbird uses VISTA buzz to secure $290M pact for tumor drug

Hummingbird could one day feather its nest with up to $290 million if its decision to license a phase 2-ready cancer drug to Percheron pays off.
James Waldron Jun 26, 2025 4:53am
A series of dice with a bag on them illustrating cost cuts

Prothena lays off 63% in fallout from phase 3 amyloidosis fail

Jun 20, 2025 2:23am
Monocled cobra

18 years of self-inflicted snakebites lead to new antivenom

May 2, 2025 2:10pm
Two white lab rats looking out of a cage

FDA plans to end animal testing for new monoclonal antibody INDs

Apr 11, 2025 1:22pm
MA

Ikena, after tough year of layoffs, merges with Inmagene

Dec 23, 2024 10:00am
Photo of an ax atop a pile of three logs

Pyxis whittles pipeline down to one clinical asset

Dec 20, 2024 6:15am